dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Nishio, Makoto |
dc.contributor.author | Felip Font, Enriqueta |
dc.contributor.author | Orlov, Sergey |
dc.contributor.author | Park, Keunchil |
dc.contributor.author | Yu, Chong-Jen |
dc.contributor.author | Tsai, Chun-Ming |
dc.date.accessioned | 2021-11-04T13:34:42Z |
dc.date.available | 2021-11-04T13:34:42Z |
dc.date.copyright | 2019 |
dc.date.issued | 2020-04 |
dc.identifier.citation | Nishio M, Felip E, Orlov S, Park K, Yu CJ, Tsai CM, et al. Final Overall Survival and Other Efficacy and Safety Results From ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged NSCLC. J Thorac Oncol. 2020 Apr;15(4):609–17. |
dc.identifier.issn | 1556-1380 |
dc.identifier.uri | https://hdl.handle.net/11351/6497 |
dc.description | Ceritinib; NSCLC; Fase II |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | Journal of Thoracic Oncology;15(4) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Pulmons - Càncer - Quimioteràpia |
dc.subject | Avaluació de resultats (Assistència sanitària) |
dc.subject.mesh | Lung Neoplasms |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Treatment Outcome |
dc.title | Final Overall Survival and Other Efficacy and Safety Results From ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged NSCLC |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/j.jtho.2019.11.006 |
dc.subject.decs | neoplasias pulmonares |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | resultado del tratamiento |
dc.relation.publishversion | https://doi.org/10.1016/j.jtho.2019.11.006 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Nishio M] Thoracic Medical Oncology Department, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan. [Felip E] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Orlov S] Department of Thoracic Oncology, Pavlov First Saint Petersburg State Medical University, St. Petersburg, Russia. [Park K] Division of Hematology and Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. [Yu CJ] Department of Internal Medicine, National Taiwan University, Taipei, Taiwan. [Tsai CM] Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan |
dc.identifier.pmid | 31778798 |
dc.identifier.wos | 000522855800023 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |